FDA approves head lice treatment

Author(s):

The U.S. Food and Drug Administration has approved Natroba (spinosad) Topical Suspension 0.9% for the treatment of head lice in patients 4 years and older. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm240302.htm.

LEAVE A REPLY

Please enter your comment!
Please enter your name here